Search alternatives:
significant potential » significant positive (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
potential decrease » potential defense (Expand Search), potential decline (Expand Search), potentially increased (Expand Search)
Showing 841 - 860 results of 6,023 for search '(( significant decrease decrease ) OR ( significant potential decrease ))~', query time: 0.44s Refine Results
  1. 841
    FT-IR results.

    FT-IR results. by Caglar Akcay (6910697)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 842
    FT-IR results.

    FT-IR results. by Caglar Akcay (6910697)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 843
    FT-IR results.

    FT-IR results. by Caglar Akcay (6910697)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 844
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal malignancies’ adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 845
    3D and 2D pose of the docked 4-hydroxyestrdiol diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked 4-hydroxyestrdiol diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 846
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 847
    The role of glyoxalase system in methylglyoxal detoxification.

    The role of glyoxalase system in methylglyoxal detoxification. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 848
    IC<sub>50</sub> values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tested compounds.

    IC<sub>50</sub> values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 849
    3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 850
    Classification of inactive compounds.

    Classification of inactive compounds. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 851
    Active compounds identified as glyoxalase-I inhibitors.

    Active compounds identified as glyoxalase-I inhibitors. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 852
    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are displayed.

    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 853
    3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 854
    GSEA and GSVA enrichment analysis.

    GSEA and GSVA enrichment analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 855
    Construction of diagnostic model of ERSRGs.

    Construction of diagnostic model of ERSRGs. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 856
    Immuno-infiltration analysis.

    Immuno-infiltration analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 857
    Flow chart of the study process.

    Flow chart of the study process. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 858
    Differential analysis of SIC.

    Differential analysis of SIC. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 859
    The degree score of 13 DE-ERSRGs.

    The degree score of 13 DE-ERSRGs. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 860
    GSVA results.

    GSVA results. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: